Spectrum Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
SPPI Spectrum Pharmaceuticals Inc
FDBC Fidelity D&D Bancorp Inc
$BUKCHET Bloomberg Coffee Subindex Euro
BMY Bristol-Myers Squibb Co
MLGO MicroAlgo Inc
FRST Primis Financial Corp
VII 7GC & Holdings Co Inc
PEBO Peoples Bancorp Inc
BIOAF Bioasis Technologies Inc
NRGOF Newrange Gold Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Closing Price
$0.8198
Day's Change
0.0098 (1.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.83
Day's Low
0.7988
Volume
(Light)
Volume:
1,129,883

10-day average volume:
2,318,281
1,129,883

AMC stock tumbles after reporting 12th consecutive quarterly loss

7:50 am ET November 9, 2022 (MarketWatch)
Print

By James Rogers

Theater chain reports a slightly wider loss than last year and revenue that tops analysts' estimates

AMC Entertainment Holdings Inc. reported its 12th consecutive quarterly loss and revenue that topped analysts' estimates after market close on Tuesday, sending shares lower in after-hours trading.

The movie-theater chain and meme-stock phenomenon reported a third-quarter net loss of $226.9 million, or a net loss of 22 cents a share, compared with a net loss of $224.2 million, or a net loss of 22 cents a share, in the same period last year. On an adjusted basis, AMC (AMC) reported a net loss of 20 cents a share, better than an adjusted loss of 22 cents a share a year ago. The company has not reported a profitable quarter on a GAAP basis since nearly a year before the pandemic, in the second quarter of 2019.

AMC's second-quarter sales were $968.4 million, compared with $763.2 million in the same period last year. Analysts surveyed by FactSet were looking for sales of $961 million and a net loss of 20 cents a share, or a net loss of 23 cents a share on an adjusted basis.

Related: Is the golden age of the meme-stock rally over?

The company's stock fell 4% in after-hours trading following the release of the results. Shares of the meme-stock darling, which skyrocketed to a high of $72.62 on June 2, 2021, have fallen 66.5% this year. AMC's stock, which has a 52-week high of $27.30, closed up 5.4% to $5.62 on Tuesday.

"Exactly as anticipated and foreshadowed on our last quarterly earnings call, our third-quarter results were impacted by a particularly soft industry-wide box office in the latter two-thirds of the 2022 third quarter," said AMC CEO Adam Aron, in a statement.

However, AMC's admissions revenue and food and beverage spending remain well above prepandemic levels, growing 12% and 30%, respectively, compared with the third quarter of 2019, according to Aron.

AMC, which describes itself as the largest movie-theater company in the world, reported adjusted EBITDA of a $12.9 million loss, compared with a loss of $5.4 million in the same period last year.

See now: Are you tempted to buy AMC's new APEs? Be prepared to lose everything, the company warns

AMC ended the third quarter with just under $895.8 million of liquidity. "We will use it to continue to grow but also to continue to de-lever," said Aron during a conference call to discuss the results.

Aron also explained that AMC is in the "final throes" of developing an AMC-branded credit card. The card, he said, will be launched in the first quarter of 2023, "if not sooner."

The CEO also provided an update on the company's plans for its branded popcorn. "AMC Perfectly Popcorn will be in grocery stores across the U.S. in the first half of 2023," he said.

The movie-theater chain has been on a roller-coaster ride over the past two years that took it from beleaguered pandemic victim to meme-stock phenomenon. AMC used the steep rise in its share price to tap into equity and debt markets, raising $917 million in January 2021.

The company's AMC Preferred Equity Units , or APEs, made their trading debut in August, sparking volatility.

With its APE equity unit, AMC created something like a 2-for-1 stock split, marking the company's latest effort in a fight over stock issuances. AMC is also taking aim at its massive debt burden with the APE special dividend. The name is a nod to the investors who turned the company into a meme stock, who often refer to themselves as "apes" or "ape nation." AMC issued an APE for each of its roughly 517 million shares outstanding.

The APEs, which hit an intraday low of $1.41 on Monday, have fallen 73.3% since their debut. The dividend hit an intraday high of $10.50 on Aug. 22.

See Now: AMC stock lifted by 'Zoom Rooms' partnership with Zoom

As of Tuesday, AMC has sold approximately 14.9 million sharesof its APEs and has raised net proceeds of approximately $36.4 million, the company said.

-James Rogers

	

(END) Dow Jones Newswires

November 09, 2022 07:50 ET (12:50 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.